Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder

Recruiting

Phase 3

BNC210Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1

Sponsor:

Bionomics Limited

Code:

NCT06510504

Conditions

Social Anxiety Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

225 mg BNC210

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-29. This information was provided to ClinicalTrials.gov by Bionomics Limited on 2025-04-17.